Indications for the drug Nexium®
gastroesophageal reflux disease:
- treatment of erosive reflux esophagitis;
- long-term maintenance treatment after healing of erosive reflux esophagitis to prevent relapse;
- symptomatic treatment of gastroesophageal reflux disease;
peptic ulcer of the stomach and duodenum (as part of combination therapy):
- treatment of duodenal ulcer associated with Helicobacter pylori;
— prevention of relapses of peptic ulcers associated with Helicobacter pylori;
long-term acid-suppressing therapy in patients who have suffered bleeding from a peptic ulcer (after intravenous use of drugs that reduce the secretion of gastric glands to prevent relapse);
Patients taking NSAIDs for a long time:
- healing of stomach ulcers associated with taking NSAIDs;
- prevention of gastric and duodenal ulcers associated with taking NSAIDs in patients at risk.
Zollinger-Ellison syndrome or other conditions characterized by pathological hypersecretion of the gastric glands, incl. idiopathic hypersecretion.
